Form 8-K · Current report
Avery Dennison 8-K, filed Jul 30, 2026
- Filed
- CIK
- 0000008818
- Accession no.
- 0000008818-26-000127
Summary
Avery Dennison reported preliminary, unaudited second-quarter 2026 results, with net sales of $2.5 billion (up 10.9%) and adjusted EPS of $2.89 (up 19.4%), and guided full-year 2026 reported EPS to $9.40–$9.70 and adjusted EPS to $10.00–$10.30. CEO Deon Stander credited stronger-than-anticipated sales growth, margin expansion and productivity measures, while the company cited tariffs, geopolitical uncertainty, raw material costs and currency swings among near-term risks.
Key points
- Second-quarter 2026 reported EPS was $2.67 and adjusted EPS was $2.89, up 19.4%.
- Materials Group sales rose 15.9% to $1.8 billion, while Solutions Group sales fell 0.5% to $667 million.
- The company returned $347 million to shareholders in the first half of 2026 through buybacks and dividends, and net debt to adjusted EBITDA was 2.3x.
- First-half restructuring actions produced about $34 million in pre-tax savings against roughly $34 million in pre-tax restructuring charges.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. Avery Dennison Corporation’s (the “Company’s”) press release, dated July 30, 2026, announcing its preliminary, unaudited financial results for second quarter 2026 and guidance for full-year 2026, is attached hereto as Exhibit 99.1 and being furnished (not filed) with this Form 8-K. The Company’s supplemental presentation materials, dated July 30, 2026, regarding its preliminary, unaudited financial review and analysis for second quarter 2026 and guidance for full-year 2026, is attached hereto as Exhibit 99.2 and being furnished (not filed) with this Form 8-K. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.